Outcomes of Tisagenlecleucel in Lymphoma Patients With Predominant Management in an Ambulatory Setting
在以门诊治疗为主的淋巴瘤患者中,Tisagenlecleucel 的疗效
期刊:Clinical Lymphoma Myeloma & Leukemia
影响因子:2.7
doi:10.1016/j.clml.2022.04.012
Nasta, Sunita D; Hughes, Mitchell E; Namoglu, Esin C; Garfall, Alfred; DiFilippo, Heather; Ballard, Hatcher J; Barta, Stefan K; Chong, Elise A; Frey, Noelle V; Gerson, James N; Landsburg, Daniel J; Ruella, Marco; Schuster, Stephen J; Svoboda, Jakub; Weber, Elizabeth; Porter, David L